The Journal of Bone and Joint Surgery (American). 2006;88:2060-2068.
doi:10.2106/JBJS.F.00049
© 2006 The Journal of Bone and Joint Surgery, Inc.
Postoperative Delirium After Hip Fracture
Benjamin D. Robertson, MD1 and
Timothy J. Robertson, MD2
1 Department of Orthopaedic Surgery, University of Minnesota, 2450 Riverside
Avenue South, Suite R200, Minneapolis, MN 55454. E-mail address:
benbeckyr{at}yahoo.com
2 Behavioral Health Department, Luther Midelfort/Mayo Health System, 1400
Bellinger Street, Eau Claire, WI 54702-1510
The authors did not receive grants or outside funding in support of their
research for or preparation of this manuscript. They did not receive payments
or other benefits or a commitment or agreement to provide such benefits from a
commercial entity. No commercial entity paid or directed, or agreed to pay or
direct, any benefits to any research fund, foundation, educational
institution, or other charitable or nonprofit organization with which the
authors are affiliated or associated.
 |
Introduction
|
|---|
A hip fracture is
sustained by 250,000 Americans every year. The most common complication
associated with hip fracture is delirium.
Delirium is a serious
medical condition that consists of a disturbance of consciousness with a
reduced ability to focus, sustain, or shift attention.
Multiple studies have
shown that patients with postoperative delirium are less likely to return to
their preinjury level of function, are more frequently placed in nursing
homes, and ultimately have an increased rate of mortality.
Delirium can be
completely prevented in up to one-third of at-risk patients. When delirium
cannot be prevented, the prevalence of severe delirium can be reduced by up to
50%.
Optimal treatment of
delirium requires excellent teamwork among the orthopaedic surgeon,
anesthesiologist, internist or geriatrician, and others.
A hip fracture is sustained by 250,000 Americans every
year1, and that
number is expected to double by
20402. The most
frequent complication associated with hip fracture in elderly patients is
postoperative
delirium3, with a
prevalence ranging between 5% and 61%, depending on the patient
population1,3-8.
Delirium is often undetected, misdiagnosed, or
undertreated9-11.
However, this condition has severe consequences for the
patient4,5,11.
The focus of this article is to provide an overview of current knowledge
regarding the outcomes, pathogenesis, diagnosis, prevention, and treatment of
postoperative delirium in elderly patients treated for a hip fracture.
 |
Definition
|
|---|
For the purposes of this article, delirium and acute confusional states are
synonymous. Delirium consists of a "disturbance of consciousness....
with reduced ability to focus, sustain, or shift attention." There is
also "a change in cognition... or the development of a perceptual
disturbance that is not better accounted for by a preexisting, established, or
evolving
dementia."12
The diagnostic criteria for delirium have been established by the American
Psychiatric Association (Table
I)12.
It is important to be aware of, and to use, these criteria because many of the
signs and symptoms of delirium are also associated with conditions such as
dementia, depression, and psychosis. Table
II summarizes some of the distinguishing characteristics of these
diagnoses13.
 |
Why Should We Care?
|
|---|
Deep vein thrombosis and the subsequent risk of death from pulmonary
embolus have received a great deal of attention in the orthopaedic literature.
The morbidity and mortality associated with postoperative delirium are far
greater than those associated with deep vein
thrombosis6, and yet
postoperative delirium has received very little attention in the orthopaedic
literature.
Gustafson et al. studied 111 consecutive patients who had undergone surgery
for a femoral neck
fracture6. They
evaluated the patients for preexisting dementia and, with use of the
DSM-III6 (Diagnostic
and Statistical Manual of Mental Disorders, Third Edition), examined them
preoperatively and postoperatively for the development of delirium.
Sixty-eight (61%) of the 111 patients became acutely confused: 33% were in an
acute confusional state preoperatively and another 28% were in an acute
confusional state postoperatively. Gustafson et al. followed all patients for
six months after the operation and found a significant difference in the
length of the stay in the hospital (p < 0.05) as well as in postoperative
complications such as urinary incontinence (p = 0.0005), feeding problems (p =
0.05), and decubitus ulcers (p = 0.01). In addition, patients with delirium
had an increased likelihood of dying or being placed in a nursing home for the
first time, and they were less likely to regain their prefracture walking
level.
In a similar study, Marcantonio et al. evaluated 126 consecutive patients,
more than sixty-five years old, who had sustained a hip
fracture1. They
examined them preoperatively, daily after the operation, and at one and six
months postoperatively. Delirium developed in 41% (fifty-two) of the 126
patients; it persisted in fifteen patients at one month and in three patients
at six months. Patients who had delirium had a significantly greater decline
in activities of daily living (odds ratio, 2.6; 95% confidence interval, 1.1
to 6.1), a significantly greater decline in walking ability (odds ratio, 2.6;
95% confidence interval, 1.03 to 6.5), and a significantly higher rate of
death or new placement in a nursing home (odds ratio, 3.0; 95% confidence
interval, 1.1 to 8.4) during the follow-up period than those without delirium.
In addition, patients whose delirium persisted had worse outcomes in those
categories than patients whose delirium resolved.
Edelstein et al. followed 921 patients for the development of delirium
after hip fracture5.
Although they reported a much lower prevalence (5.1%) than the authors
mentioned above, they examined the patients for delirium at only one point in
time after the operation and they selected healthier patients with their
inclusion and exclusion criteria. They did show that patients with delirium
had a significant increase in the length of the overall hospital stay (p <
0.001) and increased mortality (p = 0.02) at one year. In addition, their
patients were less likely to regain their prefracture level of walking (p =
0.03) and activities of daily living (p < 0.001).
Medically ill elderly individuals in whom delirium develops during
hospitalization have an increased chance of dying during that hospitalization
(an 11% rate of death in the first month after discharge and a 25% rate within
six months12).
The above reports document the substantial impact of delirium on patient
outcomes, with increased rates of mortality or new nursing home placement
postoperatively and longer, more
expensive14
hospital stays. Prolonged delirium is also a risk factor for the development
or worsening of dementia. Finally, delirium is upsetting for the patient and
their loved ones. For all of these reasons, delirium requires our
attention.
 |
Pathogenesis
|
|---|
The pathogenesis of delirium is not fully understood. Part of the
difficulty in studying delirium stems from the fact that it is transient and
may often have multiple underlying
causes15-19.
Delirium has been considered to be a generalized, nonspecific dysfunction of
the higher cortical processes because electroencephalograms of delirious
patients have shown diffuse
slowing16,18.
However, studies of
animals15 as well
as studies of lesions in patients who have sustained a stroke or traumatic
brain injury and functional brain imaging in
humans18 offer
insight regarding which areas of the brain and which neurotransmitters are
primarily affected.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 1 A schematic diagram showing how various risk factors can affect
acetylcholine and dopamine levels, leading to delirium. ACH = acetylcholine,
DA = dopamine, and HOTN = hypotension.
|
|
Similar to specific tracts in the spinal cord, there are tracts within the
brain that are involved in our higher cortical functioning. These tracts are
best thought of as parallel yet integrated
circuits19,20.
Wakefulness, attention, mood, and sleep appear to require sustained coherent
activity in these various corticothalamic networks. These neural networks seem
to be uniquely sensitive to the metabolic and other changes that are thought
to generate delirium. Areas in the parietal and temporal cortices related to
attention as well as in the reticular activating system in the brainstem are
also
affected18-23.
Within the brain, there are a number of neurotransmitters that are
responsible for overall brain
function15-18,24.
There are two major neurotransmitters: gamma-aminobutyric acid, which is
inhibitory, and glutamate, which is excitatory. There are also four modulatory
neurotransmitters that are very important in brain function and dysfunction:
acetylcholine, dopamine, serotonin, and norepinephrine. Psychiatrists target
these modulatory neurotransmitters with various psychotropic medications in
order to treat psychiatric
illnesses25-27.
Alterations in each of these neurotransmitters have been found in patients
with
delirium15-19.
In addition, these neurotransmitter systems are not mutually exclusive but
interact
extensively24.
A decrease in acetylcholine and an increase in dopamine appear to have
important roles in the development of
delirium15,17,19.
Decreased acetylcholine is also found in
dementia28.
Acetylcholine is important in arousal, attention, memory, and rapid eye
movement (REM) sleep, all of which can be affected during
delirium15,17,19.
Delirium can be induced experimentally by administering anticholinergic drugs,
and it can be reversed by administering physostigmine (a cholinergic agent) or
antipsychotic medications such as
haloperidol19.
Furthermore, serum levels of anticholinergic activity, which are usually
measured only in research settings, are increased during delirium, and higher
levels correlate with greater cognitive impairment. Dopamine, on the other
hand, is thought to change reciprocally with
acetylcholine15,19;
intoxication with dopamine can induce
delirium19. The use
of postoperative opiates can contribute to delirium by increasing dopamine
activity while decreasing acetylcholine
levels19.
Hypoglycemia or hypoxia also can result in decreased levels of acetylcholine
and, in susceptible individuals,
delirium19,29,30.
Finally, anything that causes an inflammatory response, such as infection,
trauma, or operative intervention, causes the release of
cytokines15,17.
Cytokines, which include interleukins, tumor necrosis factor (TNF), and
interferon-alpha, also increase dopamine levels and decrease acetylcholine
levels15,17,31.
The impact of aging on the brain also needs to be
considered17. With
aging, there are morphologic changes in the brain, including a decrease in
overall volume, a decrease in the number and volume of neurons, and a loss of
dendrites and synapses. In addition to these morphologic changes, there are
hormonal changes, such as an increased basal level of cortisol. Also, there is
an overall decrease in the level of acetylcholine as a result of a decrease in
choline acetyl transferase activity, which is important in acetylcholine
synthesis, combined with no change in acetylcholinesterase, the enzyme
responsible for acetylcholine breakdown. This decrease in acetylcholine
contributes to the memory impairment that occurs with aging and, in a more
pronounced way, with Alzheimer's dementia. Lastly, there is an increase in the
basal release of dopamine. The result of these age-related changes is a
decreased brain reserve for handling metabolic and other stresses. The impact
of various risk factors on the levels of acetylcholine and dopamine is
summarized in Figure
15,17,32,33.
 |
Diagnosis
|
|---|
Diagnosing delirium requires a high index of suspicion, with an
understanding that delirium will develop in nearly 50% of patients who have
sustained a hip fracture. Use of the DSM-IV-TR (Diagnostic and Statistical
Manual of Mental Disorders, Fourth Edition, Text Revision) criteria
(Table I) or an instrument such
as the CAM (Confusion Assessment Method) algorithm
(Table
III)11,16
at the bedside increases the likelihood of making the correct
diagnosis7,11,15,34.
The CAM, which is based on DSM-III-R criteria, has been validated in a number
of
settings11,15,34.
It has high sensitivity and specificity and can be administered in
approximately two to five
minutes11,15.
As part of the assessment for symptoms of delirium, it is important to
understand the patient's baseline level of cognitive and other functioning. If
the patient is not displaying symptoms of delirium on admission, baseline
cognitive functioning can be assessed at that time with use of the Mini-Mental
State
Examination35. This
simple examination is easy to administer and should be part of the
preoperative
evaluation36.
Baseline functioning can also be determined by interviewing family members and
reviewing medical records.
Symptoms such as agitation, delusions, or hallucinations are easy to
observe but are present in only a minority of
cases4. The more
common, or core, symptoms are reduced clarity of awareness of the environment
with a reduced ability to focus, shift, or sustain attention and cognitive
changes such as memory loss, disorientation, or changes in language, including
rambling, incoherent, or difficult-to-follow
speech7. These
findings can be more subtle and in part account for missed diagnoses. Also,
recognizing delirium as it is developing may be
helpful37.
Disorientation and urgent calls for attention by the patient are the most
predictive prodromal
changes38.
When a diagnosis of delirium is being considered during the perioperative
period for a patient with a hip fracture, it is important to keep in mind the
differential diagnosis of alcohol withdrawal, delirium tremens, or fat emboli
syndrome39,40.
These conditions will be discussed only briefly because they are not the focus
of this article.
Alcohol withdrawal occurs primarily in heavy drinkers (more than five
drinks per day). It is essential to obtain a history regarding alcohol (or
other substance) abuse from the patient and family members in order to be
alert to the possibility of alcohol or other withdrawal syndromes. Withdrawal
symptoms generally begin five to ten hours after the last drink, peak within
forty-eight to seventy-two hours, and subside within five to seven days,
although they can last longer. Postoperative pain medication can mask
withdrawal symptoms as can concurrent illness or an
operation39.
Alcohol withdrawal is characterized by symptoms of autonomic hyperactivity
such as diaphoresis; tachycardia; systolic hypertension; hand and body
tremors; transient tactile, auditory, or visual hallucinations; anxiety;
nausea and vomiting; psychomotor agitation; and occasionally seizures. A
patient undergoing alcohol withdrawal is alert, oriented, aware of his or her
environment, and able to attend. In patients with delirium tremens, alcohol
withdrawal is complicated by frank
delirium39.
Fat emboli syndrome occurs within twenty-four to forty-eight hours
following femoral neck fracture in 0.5% to 3% of individuals. It is
characterized by pulmonary distress, changes in mental status, and a petechial
rash in nondependent areas such as the axillae, the anterior surface of the
neck, the chest, the area around the navel, and the conjunctiva and
oropharynx. There can also be fever, tachycardia, jaundice, renal changes, and
retinal
changes40.
 |
Prevention and Treatment
|
|---|
Often, delirium is preventable or its severity can be lessened, but
unfortunately there is no single intervention that has been shown to prevent
delirium1,7,37.
Instead, reducing the incidence and severity of delirium relies on optimizing
the medical and surgical care of the
patient1,7,37
in order to maximize neuronal functioning. If delirium does develop, treatment
then centers on supportive care and identifying and addressing the underlying
cause or
causes1,41.
Most surgeons direct the postoperative pain control for their patients.
Opiates can contribute to delirium by increasing dopamine levels and
decreasing acetylcholine
levels16,19.
However, Morrison et al. demonstrated that delirium can also be associated
with too little pain
control3. They used
multiple logistic regression analysis to identify risk factors in a study of
541 patients with a hip fracture. Severe pain significantly increased the risk
of delirium (risk ratio, 9; 95% confidence interval, 1.8 to 45.2). In
addition, delirium was more likely to develop in patients who received <10
mg of parenteral morphine sulfate equivalents per day than it was in patients
who received more analgesia (risk ratio, 5.4; 95% confidence interval, 2.4 to
12.3). Finally, patients who received meperidine (Demerol) were at increased
risk for the development of delirium compared with those who received other
opioid analgesics (risk ratio, 2.4). This was probably due to the
anticholinergic effects of meperidine.
The type of anesthesia administered does not appear to affect the
development of delirium. In the same study by Morrison et
al.3, there was no
significant difference between the delirium rates associated with regional and
general anesthesia. Gustafson et
al.6 showed a trend
toward increased delirium with spinal anesthesia; however, it was not
significant. They found that a drop in blood pressure below 80 mm Hg was more
important, and this more commonly occurred with spinal anesthesia.
Approximately 90% of their patients who had this decrease in blood pressure
went on to have
delirium6,33.
Edelstein et al.5
reported a higher prevalence of delirium with general anesthesia and
postulated that that higher prevalance may be due to cerebral hypoxia during
general anesthesia. However, it appears that the ability to maintain oxygen
delivery to the brain during surgery is more important than the type of
anesthesia administered.
Other investigators have concentrated more on optimizing the perioperative
medical care of patients with a hip fracture in an attempt to decrease the
prevalence of delirium. The intervention reported by Gustafson et
al.33 consisted of
preoperative and postoperative geriatric assessments as well as aggressive
management of perioperative conditions and postoperative complications. The
prevalence of delirium decreased from 61.3% in their observational cohort to
47.6% in their intervention group (p < 0.05). The prevalence of severe
delirium was also significantly lower in their intervention group (30%
compared with 7%) (p < 0.0001). The hospital stay decreased from seventeen
to eleven days (p < 0.001), and rates of postoperative complications such
as urinary retention, decubitus ulcers, and severe falls all decreased.
Milisen et al.42
evaluated the impact of increased involvement by nurses on delirium in a
prospective, randomized study of two groups of sixty patients with a hip
fracture. Their intervention consisted of educating nursing staff to recognize
delirium, systematic cognitive screening of patients, a scheduled pain
protocol, and the availability of a consulting geriatric nurse or physician.
Although they did not find a significant decrease in the prevalence of
delirium, they did observe a significant decrease in the duration (p = 0.03)
and severity (p = 0.015) of delirium.
Marcantonio et
al.8 performed a
prospective, randomized, blinded study to investigate the effect of a
structured geriatrics consultation on the development of delirium after hip
fracture surgery. The intervention group received a proactive geriatrics
consult either preoperatively or within twenty-four hours after surgery. The
geriatrician made daily visits for the duration of the hospital stay and gave
targeted recommendations based on a structured protocol. The prevalence of
delirium was 32% in the intervention group compared with 50% in the usual-care
group (p = 0.04), and the prevalence of severe delirium was decreased as well
(12% compared with 29%). This study emphasized that delirium can be prevented
or lessened in many patients but that there is no single intervention that
consistently prevents delirium. Efforts to prevent delirium need to focus on
minimizing the number of metabolic or other potential central nervous system
insults that the patient experiences once admitted to the hospital. A
patient's age, cognitive status, fracture, or need for surgery cannot be
prevented. In some patients, these four factors alone will be sufficient to
induce delirium. However, some patients have enough brain reserve to withstand
these insults, and it is other insults, such as a decrease in blood pressure,
hypoxia, urinary tract infection, or uncontrolled pain, that eventually
trigger delirium. Reducing or eliminating these insults can prevent delirium
in many patients or can decrease its severity.
If delirium does develop, treatment then focuses on supportive care,
identification of likely precipitants, and treatment of any underlying causes
that can be corrected (Table
IV)8,33,41.
This generally involves a dedicated team including the orthopaedic surgeon,
nursing staff, and consulting specialist(s) with experience and expertise in
diagnosing and treating delirium. Medical management must be reviewed and
optimized, and the team must systematically rule out potential causes of
new-onset delirium. Table V
provides an organized approach for prevention and treatment of delirium in
patients with a hip fracture.
Physical examination should include measurement of vital signs with pulse
oximetry, assessment of signs suggestive of alcohol withdrawal, and an
investigation for evidence of fat emboli syndrome. It is also important to
look for any localizing signs of wound or other infections and to assess
hydration. Thyroid, heart, lung, abdominal (including the lower abdomen
because a distended bladder can be evidence of anticholinergic excess), and
neurological examinations are important as well. A rectal examination is
recommended if there is concern about severe constipation or
impaction15,16,36,41.
Important laboratory and radiographic studies are listed in
Table IV.
Any pertinent abnormalities identified through a review of the history, a
review of systems, or physical and laboratory examinations should be
corrected, with a focus on adequate oxygenation, restoring fluid and
electrolyte balance, treating pain, eliminating or weaning the patient off of
unnecessary medications, regulating bowel and bladder function, providing
adequate nutritional intake, mobilizing the patient if possible, addressing
any vision or hearing impairments, normalizing the sleep-wake cycle, and
providing appropriate environmental stimuli, reassurance, orientation, and
support8,15,16,37,41.
Regarding pain control, the natural response when a patient has delirium is to
withdraw narcotic medication. However, as Morrison et
al.3 demonstrated,
inadequate pain control may also contribute to delirium.
If the underlying cause or causes of delirium are corrected, the course of
the delirium is often self-limited and the patient recovers completely. If the
cause or causes persist, delirium can persist and progress to dementia.
Although dementia is a risk factor for delirium, delirium is also a risk
factor for
dementia9,43.
Thus, the prognosis for an episode of delirium appears to improve when the
duration is
shorter8.
If a patient with delirium is agitated, delusional, or hallucinating or is
too inattentive or confused to cooperate with treatment, adjunctive medication
may be
needed15,36,41.
Treating these symptoms can diminish the patient's distress, decrease the risk
of patient injury, and reduce excessive energy expenditure. The most
frequently used and studied medication in this situation is Haldol
(haloperidol), a first-generation antipsychotic medication, although there are
few studies to guide
treatment15,35,36,41.
Haldol; the second-generation antipsychotic medications Zyprexa (olanzapine),
Risperdal (risperidone), Seroquel (quetiapine fumarate), and Geodon
(ziprasidone); or the third-generation antipsychotic agent Abilify
(aripiprazole) can help to reduce confusion, agitation, or hallucinations by
decreasing dopamine levels, thereby improving the acetylcholine-todopamine
ratio. Because there is a small risk of potentially fatal torsade de
pointes (ventricular tachycardia characterized by polymorphic QRS
complexes) with intravenous Haldol, baseline and follow-up electrocardiograms
(to look for prolongation of the QTc interval) and serum potassium and
magnesium monitoring are
needed41. Safety is
further increased by utilizing continuous cardiac telemetry
monitoring19.
The newer antipsychotic agents can be more difficult to regulate than
Haldol, which has minimal anticholinergic side effects and no active
metabolites44. The
newer antipsychotic agents also have pharmacologic effects beyond reducing
dopamine levels44
that can make it difficult to determine whether they are diminishing or
exacerbating delirium. They are sometimes utilized on a scheduled basis with
use of Haldol as an as-needed agent for breakthrough
symptoms45.
In addition to extrapyramidal side effects (muscle tightening or Parkinson
symptoms), antipsychotic medication can cause akathisia (a subjective sense of
restlessness and an inability to sit still) or, rarely, neuroleptic malignant
syndrome (which consists of a high fever, muscle rigidity, and autonomic
instability). Tardive dyskinesia (abnormal movements of the tongue, mouth,
arms, legs, and trunk) primarily occurs with long-term use but can occur with
short-term use. Elderly women constitute a group at high risk for tardive
dyskinesia44. Also,
the United States Food and Drug Administration (FDA) recently determined that
second and third-generation antipsychotic medications are associated with a
1.6 to 1.7-fold increase in death (from cardiac-related events such as heart
failure or sudden death, or infections, especially pneumonia) of elderly
patients with dementia when used to treat behavioral
disorders46. The
FDA is considering adding a similar warning to Haldol and other
first-generation
antipsychotics46.
Zyprexa and Risperdal are also associated with a small risk of stroke and
other adverse cerebrovascular events in elderly patients with
dementia47,48.
Because of these possible adverse effects, antipsychotic medication should be
carefully titrated to the most effective dose and used only as long as it is
needed to control the above-noted deleterious behaviors associated with
delirium.
Other medications, such as benzodiazepines or physostigmine, are used less
frequently41.
Benzodiazepines are useful for managing alcohol or sedative-hypnotic
withdrawal and delirium
tremens39. They can
also be used to augment antipsychotic medication in the treatment of delirium
when larger doses appear to be
needed41.
Benzodiazepines are usually not effective as monotherapy for general cases of
delirium and can cause behavioral disinhibition, especially in the
elderly41.
Physostigmine, which is a cholinergic medication, is useful only if the
delirium is known to be caused by an anticholinergic
medication41.
Physostigmine is associated with a higher risk of side effects, including
seizures, bradycardia, asystole, bronchospasm, and pulmonary edema, than are
antipsychotic
medications49.
Aricept (donepezil) has been occasionally used as a safer alternative to
physostigmine in these
situations50.
 |
Overview
|
|---|
Delirium is a serious medical condition that consists of a disturbance of
consciousness with a reduced ability to focus, sustain, or shift attention.
There are also cognitive and/or perceptual changes. Delirium generally
develops over a period of hours to days and tends to fluctuate over the course
of the day. It is a frequent and dangerous complication of hip fracture in the
elderly that has received little attention in the orthopaedic literature.
However, multiple
studies1,5,6
have shown that postoperative delirium following hip fracture is associated
with prolonged hospital stays, higher costs, and poor outcomes. Patients who
experience delirium are less likely to return to their prefracture level of
walking or activities of daily living. They are also substantially more likely
to be placed in a nursing home for the first time and to die.
Although the pathophysiology of delirium is not fully understood, it
appears that multiple metabolic and neurochemical insults disrupt neuronal
functioning in susceptible areas, especially in the corticothalamic networks.
These insults commonly lead to an imbalance in the dopamine-to-acetylcholine
ratio in these important brain regions. Prevention and optimal treatment
consist of minimizing or correcting these metabolic and other insults.
Maintaining oxygen saturation at >90%, systolic blood pressure at >90 mm
Hg, and the hematocrit at >30% is important, as is attention to the fluid
and electrolyte status. Pain control, careful review of the patient's
medications, regulation of bowel and bladder function, adequate nutritional
intake, early mobilization and rehabilitation, appropriate environmental
stimulation, and normalization of the patient's sleep-wake cycle are also key.
Early detection of coexisting or postoperative medical problems, infections,
or other complications is crucial. Antipsychotic medication can be used to
reduce agitation that interferes with the patient's ability to cooperate with
treatment, places the patient in danger of harm, or excessively increases
metabolic demands.
There is no single intervention that can eliminate delirium. Treatment and,
when possible, prevention require awareness of the diagnosis, reduction or
elimination of modifiable risk factors, early diagnosis and treatment, and
excellent teamwork among the orthopaedist, anesthesiologist, nursing staff,
and other consulting medical specialists.
 |
Acknowledgments
|
|---|
NOTE: The authors thank Dr. Marc Swiontkowski and Dr. Terence
Gioe.
 |
References
|
|---|
- Marcantonio ER, Flacker JM, Michaels M,
Resnick NM. Delirium is independently associated with poor functional recovery
after hip fracture. J Am Geriatr Soc.2000; 48:618
-24.[Medline]
- Cummings SR, Rubin SM, Black D. The
future of hip fractures in the United States. Numbers, costs, and potential
effects of postmenopausal estrogen. Clin Orthop Relat Res.1990; 252:163
-6.
- Morrison RS, Magaziner J, Gilbert M,
Koval KJ, McLaughlin MA, Orosz G, Strauss E, Siu AL. Relationship between pain
and opioid analgesics on the development of delirium following hip fracture.J Gerontol A Biol Sci Med Sci
.2003; 58:76
-81.
- Duppils GS, Wikblad K. Cognitive
function and health-related quality of life after delirium in connection with
hip surgery. A six-month follow-up. Orthop Nurs.2004; 23:195
-203.[Medline]
- Edelstein DM, Aharonoff GB, Karp A,
Capla EL, Zuckerman JD, Koval KJ. Effect of postoperative delirium on outcome
after hip fracture. Clin Orthop Relat Res.2004; 422:195
-200.
- Gustafson Y, Berggren D, Brannstrom B,
Bucht G, Norberg A, Hansson LI, Winblad B. Acute confusional states in elderly
patients treated for femoral neck fracture. J Am Geriatr Soc.1988; 36:525
-30.[Medline]
- Bitsch M, Foss N, Kristensen B, Kehlet
H. Pathogenesis of and management strategies for postoperative delirium after
hip fracture: a review. Acta Orthop Scand.2004; 75:378
-89.[CrossRef][Medline]
- Marcantonio ER, Flacker JM, Wright RJ,
Resnick NM. Reducing delirium after hip fracture: a randomized trial. J
Am Geriatr Soc. 2001;49:516
-22.[CrossRef][Medline]
- Cole MG. Delirium in elderly patients.Am J Geriatr Psychiatry
.2004; 12:7
-21.[Abstract/Free Full Text]
- Stiefel F. Delirium: is the confusion
slowly clearing up [editorial]. Support Care Cancer.1996; 4:325
-6.[CrossRef][Medline]
- Inouye SK, van Dyck CH, Alessi CA,
Balkin S, Siegal AP, Horwitz RI. Clarifying confusion: the confusion
assessment method. A new method for detection of delirium. Ann Intern
Med. 1990:113:941
-8.[Medline]
- Delirium, dementia, and amnestic and
other cognitive disorders. In: Diagnostic and statistical manual of
mental disorders: DSM-IV. 4th ed, text revision. Washington, DC:
American Psychiatric Association; 2000. p135
-80.
- Gleason OC. Delirium. Am Fam
Physician. 2003;67:1027
-34.[Medline]
- Webster JR, Chew RB, Mailliard L, Moran
MB. Improving clinical and cost outcomes in delirium: use of practice
guidelines and a delirium care team. Ann Long-Term Care.1999; 7:128
-34.
- Samuels SC, Neugroschl JA. Delirium. In:
Sadock BJ, Sadock VA, editors. Kaplan and Sadock's comprehensive
textbook of psychiatry. 8th ed. Philadelphia: Lippincott Williams and
Wilkins; 2005. p 1054-68.
- Winawer N. Postoperative delirium.Med Clin North Am
. 2001;85:1229
-39.[CrossRef][Medline]
- van der Mast RC. Pathophysiology of
delirium. J Geriatr Psychiatry Neurol.1998; 11:138
-45.[Medline]
- Trzepacz PT. The neuropathogenesis of
delirium. A need to focus our research. Psychosomatics.1994; 35:374
-91.[Abstract/Free Full Text]
- Trzepacz PT. Delirium. Advances in
diagnosis, pathophysiology, and treatment. Psychiatr Clin North
Am. 1996;19:429
-48.[CrossRef][Medline]
- Lichter DG, Cummings JL, editors.Frontal-subcortical circuits in psychiatric and neurological
disorders
. New York: Guilford Press; 2001. Introduction
and overview; p 1-43.
- Grebb JA. Neural sciences: introduction
and overview. In: Sadock BJ, Sadock VA, editors. Kaplan and Sadock's
comprehensive textbook of psychiatry. 8th ed. Philadelphia: Lippincott
Williams and Wilkins; 2005. p1
-3.
- Zorumski CF, Isenberg KE, Mennerick SJ.
Basic electrophysiology. In: Sadock BJ, Sadock VA, editors. Kaplan and
Sadock's comprehensive textbook of psychiatry. 8th ed. Philadelphia:
Lippincott Williams and Wilkins; 2005. p99
-115.
- Arnsten AFT, Castellanos FX.
Neurobiology of attention regulation and its disorders. In: Martin A, Scahill
L, Charney DS, Leckman JF, editors. Pediatric psychopharmacology:
principles and practice. New York: Oxford University Press;2003
. p 99-109.
- Bronstein YL, Cummings JL.
Neurochemistry of frontal-subcortical circuits. In: Lichter DG, Cummings JL,
editors. Frontal-subcortical circuits in psychiatric and neurologic
disorders. New York: Guilford Press; 2001. p59
-91.
- Bronstein YL, Cummings JL.
Neuropharmacology of frontal-subcortical circuits. In: Lichter DG, Cummings
JL, editors. Frontal-subcortical circuits in psychiatric and neurologic
disorders. New York: Guilford Press; 2001. p401
-20.
- Voeller KKS.
Attention-deficit/hyperactivity disorder as a frontal-subcortical disorder.
In: Lichter DG, Cummings JL, editors. Frontal-subcortical circuits in
psychiatric and neurologic disorders. New York: Guilford Press;2001
. p 334-72.
- Tecott LH, Smart SL. Monoamine
neurotransmitters. In: Sadock BJ, Sadock VA, editors. Kaplan and
Sadock's comprehensive textbook of psychiatry. 8th ed. Philadelphia:
Lippincott Williams and Wilkins; 2005. p49
-60.
- Neugroschl JA, Kolevzon A, Samuels SC,
Marin DB. Dementia. In: Sadock BJ, Sadock VA, editors. Kaplan and
Sadock's comprehensive textbook of psychiatry. 8th ed. Philadelphia:
Lippincott Williams and Wilkins; 2005. p1068
-93.
- Magistretti PJ, Pellerin L, Martin J-L.
Brain energy metabolism: an integrated cellular perspective.
www.acnp.org/G4/GN401000064.
2000.
- Breningstall GN. Oxidative metabolism
disorders. In: Swaiman KF, Ashwal S, editors. Pediatric
neurology. Principles and practice. St. Louis: Mosby;1999
. p 483-93.
- Gustafson Y. Postoperative delirium: a
challenge for the orthopedic team [editorial]. Acta Orthop
Scand. 2004;75:375
-7.[CrossRef][Medline]
- Lundstrom M, Edlund A, Bucht G, Karlsson
S, Gustafson Y. Dementia after delirium in patients with femoral neck
fractures. J Am Geriatr Soc.2003; 51:1002
-6.[CrossRef][Medline]
- Gustafson Y, Brannstrom B, Berggren D,
Ragnarsson JI, Sigaard J, Bucht G, Reiz S, Norberg A, Winblad B. A
geriatric-anesthesiologic program to reduce acute confusional states in
elderly patients treated for femoral neck fractures. J Am Geriatr
Soc. 1991;39:655
-62.[Medline]
- Folstein MF, Folstein SE, McHugh PR.
"Mini-mental state". A practical method for grading the cognitive
state of patients for the clinician. J Psychiatr Res.1975; 12:189
-98.[CrossRef][Medline]
- Jacobi J, Fraser GL, Coursin DB, Riker
RR, Fontaine D, Wittbrodt ET, Chalfin DB, Masica MF, Bjerke HS, Coplin DW,
Crippen DW, Fuchs BD, Kelleher RM, Marik PE, Nasraway SA Jr, Murray MJ,
Peruzzi WT, Lumb PD; Task Force of the American College of Critical Care
Medicine (ACCM) of the Society of Critical Care Medicine (SCCM), American
Society of Health-System Pharmacists (ASHP), American College of Chest
Physicians. Clinical practice guidelines for the sustained use of sedatives
and analgesics in the critically ill adult. Crit Care Med.2002; 30: 119-41.
Erratum in: Crit Care Med. 2002;30:726.[CrossRef][Medline]
- Hanson MR, Galvez-Jimenez N. Management
of dementia and acute confusional states in the perioperative period.Neurol Clin
.2004; 22:vii-viii,413
-22.[CrossRef]
- Weber JB, Coverdale JH, Kunik ME.
Delirium: current trends in prevention and treatment. Intern Med
J. 2004;34:115
-21.[CrossRef][Medline]
- Duppils GS, Wikblad K. Delirium:
behavioural changes before and during the prodromal phase. J Clin
Nurs. 2004:13;609
-16.[CrossRef][Medline]
- Chang PH, Steinberg MB. Alcohol
withdrawal. Med Clin North Am.2001; 85:1191
-212.[CrossRef][Medline]
- Parisi DM, Koval K, Egol K. Fat embolism
syndrome. Am J Orthop.2002; 31:507
-12.[Medline]
- Practice guideline for the treatment of patients with
delirium. American Psychiatric Association. Am J
Psychiatry. 1999;156(5
Suppl): 1-20.[Free Full Text]
- Milisen K, Foreman MD, Abraham IL, De
Geest S, Godderis J, Vandermeulen E, Fischler B, Delooz H, Spiessens B, Broos
P. A nurse-led interdisciplinary intervention program for delirium in elderly
hip-fracture patients. J Am Geriatr Soc.2001; 49:523
-32.[CrossRef][Medline]
- Olofsson SM, Weitzner MA, Valentine AD,
Baile WF, Meyers CA. A retrospective study of the psychiatric management and
outcome of delirium in the cancer patient. Support Care Cancer.1996; 4:351
-7.[CrossRef][Medline]
- Bezchlibnyk-Butler KZ, Jeffries JJ,
editors. Clinical handbook of psychotropic drugs. 15th ed.
Ashland, OH: Hogrefe and Huber; 2005. p102
.
- Skrobik YK, Bergeron N, Dumont M,
Gottfried SB. Olanzapine vs haloperidol: treating delirium in a critical care
setting. Intensive Care Med.2004; 30:444
-9.[CrossRef][Medline]
- Deaths with antipsychotics in elderly patients with behavioral
disturbances. FDA Public Health Advisory.
www.fda.gov/cder/drug/advisory/antipsychotics.htm.
2005.
- Zyprexa. Physicians desk
reference. 59th ed. Montvale: 2005. p1901
.
- Risperdal. Physicians desk
reference. 59th ed. Montvale: 2005. p1743
.
- Physostigmine. Thomson
MICROMEDEX. 2005.
- Donepezil. Thomson
MICROMEDEX. 2005.

CiteULike Connotea Del.icio.us Technorati What's this?
Letters to the Editor:
Read all Letters to the Editor
- Perioperative Delirium
- Gary Heyburn, MRCPI, MRCGP, DRCOG
- JBJS Online, 16 Oct 2006
[Full text]
- Pulmonary Embolism As a Cause of Postoperative Delirium
- Theocharis Chr. Kyziridis
- JBJS Online, 20 Feb 2008
[Full text]
|